Event ·Multi-source

药企百亿美元AI投资或寻错优势

2026年成为制药业全面投入AI的关键一年。GSK与Noetik签署五年基础模型协议，Eli Lilly与NVIDIA共建联合创新实验室，Merck向谷歌云承诺投资十亿美元。多家药企竞相布局AI技术，但质疑这些巨额投资是否真正带来预期优势。

Current read

看看制药巨头们如何豪掷百亿美元投资AI，以及这些投入是否真的能带来竞争优势。

11 sources48° AI heatLast updated 2026/10/14 14:00:09

Evidence

11 sources

Primary sourceHIT Consultant

2026/10/14 14:00:09View source

Related source 1NVIDIA

2026/10/14 21:37:32View source

Related source 2kimmonismus

2026/10/16 13:55:27View source

Related source 3Aravind Srinivas

2026/10/12 15:26:11View source

Related source 4Genk

2026/10/12 17:01:00View source

Related source 5Rest of World

2026/10/12 17:15:01View source

Related source 6The Information

2026/10/12 18:00:17View source

Related source 7VTV Công nghệ

2026/10/12 20:25:00View source

Related source 8AI Engineer

2026/10/12 23:00:01View source

Related source 9IT之家

2026/10/13 01:31:26View source

Related source 10DavidSacks

2026/10/13 03:30:25View source

Conflict check

Dedup data only shows that these sources discuss the same event, not that they agree. There is no structured supporting or refuting evidence yet, so no conflict is inferred automatically.

Open the story